Your browser doesn't support javascript.
loading
DDX41 mutations in myeloid neoplasms are associated with male gender, TP53 mutations and high-risk disease.
Quesada, Andrés E; Routbort, Mark J; DiNardo, Courtney D; Bueso-Ramos, Carlos E; Kanagal-Shamanna, Rashmi; Khoury, Joseph D; Thakral, Beenu; Zuo, Zhuang; Yin, C Cameron; Loghavi, Sanam; Ok, Chi Y; Wang, Sa A; Tang, Zhenya; Bannon, Sarah A; Benton, Christopher B; Garcia-Manero, Guillermo; Kantarjian, Hagop; Luthra, Rajyalakshmi; Medeiros, L Jeffrey; Patel, Keyur P.
Afiliación
  • Quesada AE; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Routbort MJ; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • DiNardo CD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Bueso-Ramos CE; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Kanagal-Shamanna R; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Khoury JD; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Thakral B; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Zuo Z; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Yin CC; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Loghavi S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Ok CY; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Wang SA; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Tang Z; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Bannon SA; Department of Clinical Cancer Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Benton CB; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Kantarjian H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Luthra R; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Medeiros LJ; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Patel KP; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Am J Hematol ; 94(7): 757-766, 2019 07.
Article en En | MEDLINE | ID: mdl-30963592
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Proteína p53 Supresora de Tumor / Caracteres Sexuales / Mutación de Línea Germinal / Neoplasias Hematológicas / ARN Helicasas DEAD-box / Trastornos Mieloproliferativos Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Hematol Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Proteína p53 Supresora de Tumor / Caracteres Sexuales / Mutación de Línea Germinal / Neoplasias Hematológicas / ARN Helicasas DEAD-box / Trastornos Mieloproliferativos Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Hematol Año: 2019 Tipo del documento: Article